KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Castle Biosciences (CSTL) EPS (Weighted Average and Diluted): 2018-2025

Historic EPS (Weighted Average and Diluted) for Castle Biosciences (CSTL) over the last 8 years, with Sep 2025 value amounting to -$0.02.

  • Castle Biosciences' EPS (Weighted Average and Diluted) fell 125.00% to -$0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.45, marking a year-over-year decrease of 314.29%. This contributed to the annual value of $0.62 for FY2024, which is 128.97% up from last year.
  • Per Castle Biosciences' latest filing, its EPS (Weighted Average and Diluted) stood at -$0.02 for Q3 2025, which was down 113.33% from $0.15 recorded in Q2 2025.
  • Castle Biosciences' 5-year EPS (Weighted Average and Diluted) high stood at $0.32 for Q4 2024, and its period low was -$1.10 during Q1 2023.
  • Over the past 3 years, Castle Biosciences' median EPS (Weighted Average and Diluted) value was -$0.09 (recorded in 2024), while the average stood at -$0.21.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first plummeted by 1,066.67% in 2023, then surged by 455.56% in 2024.
  • Over the past 5 years, Castle Biosciences' EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.25 in 2021, then crashed by 216.00% to -$0.79 in 2022, then spiked by 88.61% to -$0.09 in 2023, then surged by 455.56% to $0.32 in 2024, then slumped by 125.00% to -$0.02 in 2025.
  • Its last three reported values are -$0.02 in Q3 2025, $0.15 for Q2 2025, and -$0.90 during Q1 2025.